March 13, 2017 / 8:55 PM / 8 months ago

BRIEF-Amphastar Pharma Q4 gaap loss per share $0.06

March 14 (Reuters) - Amphastar Pharmaceuticals Inc

* Amphastar Pharmaceuticals reports financial results for the three months and fiscal year ended December 31, 2016

* Q4 gaap loss per share $0.06

* Q4 revenue $63.5 million versus I/B/E/S view $55.8 million

* Q4 earnings per share view $-0.01 -- Thomson Reuters I/B/E/S

* Q4 adjusted non-GAAP earnings per share $0.01 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below